Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HI-PRO: Apixaban in Provoked VTE
NCT04168203Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in venous thromboembolism (VTE), sponsored by Brigham and Women's Hospital. Started Mar 2021; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04168203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04168203.